Investment Banking
Since 2007, JonesTrading has placed an emphasis on bridging the gap between issuers and our broad institutional investor base. We feel every corporation has its own set of unique financing demands that cannot be boxed up and placed within the confines of the traditional banking model. This distinction is the reason JonesTrading has been successful at pursuing innovative financing strategies that can be customized to fit any corporate strategy.
By offering a flexible and full suite of banking products, our capital raising solutions give our corporate customers the ability to raise capital in a more efficient and economical way.
By utilizing our network of deep-seated institutional relationships, the Investment Banking group offers a plethora of expertise and experience. Our team has a proven track record of advising corporate clients from an unbiased point of view. Our neutral position underscores our drive and commitment to achieving best execution for our customers.
- Capital On Demand®, our At-the-Market Offering Program
- Confidentially Marketed Public Offerings
- Registered Directs
- PIPEs
- Initial Public Offerings
- Syndicate
- Debt Offerings
- Advisory Services
- Committed Capital On Demand™, Equity Line of Credit
- PE/VC Exits
- Shares Repurchases
- Spot Block Transactions
- Preferred Offerings
- SPACs
- New Issuances and Recapitalizations
- Non-Deal/Deal Roadshows in US and Canada
Moe Cohen
Managing Director
Mr. Cohen played a founding role in establishing the firm’s Investment Banking Group. In 2007, Mr. Cohen launched JonesTrading’s Equity Capital Markets Group focused on Private Equity and Venture Capital public equity exit’s and At-The-Market Offerings.
Bryan Turley
Managing Director
Mr. Turley has over two decades of international experience in investment banking, capital markets, and private equity. At JonesTrading he has been Principal and Head of the Financial Institutions Group for MLV & Co. Within JonesTrading he is was critical in building out a full service FIG Banking group up and down the entire capital stack.
James O’Neill
Managing Director, Investment Banking & Equity Capital Markets
James has over 20 years of investment banking and capital markets experience supporting healthcare and emerging growth companies. In his career, James has completed over 400 transactions with an aggregate transaction value north of $20B. James most recently served as Managing Director and Head of Healthcare Capital Markets at Oppenheimer. He joined the team in September of 2023.
Jack Terranova
Managing Director, Investment Banking
Jack has over 15 years of investment banking and capital markets experience, and previously served as Managing Director in the Healthcare Investment Banking group at Oppenheimer. Mr. Terranova has completed over 100 transactions in his career, which have raised in excess of $5B for healthcare issuers. He holds a BSM in finance from Tulane University, and an MBA from The University of Colorado, Boulder.
Syndicate
The Investment Banking and Capital Markets team has extensive expertise in executing various private and public transactions. JonesTrading has served in a number of different capacities throughout a traditional syndicate structure including Sole Book Runner, Joint-Book Runner, and Lead Manager. Their experience established a proven track record of successful execution across global capital markets.
Contact:
212.907.5398
syndicate@jonestrading.com
-
RPT Rithm Property Trust
$50,000,000
9.875% Series C Fixed-to-Floating Preferred Stock
Co-Manager
-
ONVO Organovo Holdings, Inc
$5,300,000
At-the-Market
Sales Agent
-
HOVR New Horizon Aircraft Ltd
$11,000,000
At-the-Market
Sole Sales Agent
-
ARR Armour Residential REIT, Inc
24,049,043 shares
At-the-Market
Sales Agent
-
LEXX Lexaria Bioscience Corp
$5,000,000
At-the-Market
Sole Sales Agent
-
EVAX Evaxion
$10,800,000
Follow-On
Joint Bookrunner
-
KNW Know Labs
$5,000,000
At-the-Market
Sole Sales Agent
-
PAXS Pimco
$250,000,000
PAXS – At-the-Market
Sole Sales Agent
-
PDI Pimco
$2,000,000,000
PDI – At-the-Market
Sole Sales Agent
-
IVR Invesco Mortgage Capital, Inc.
11,095,561 shares
At-the-Market
Sales Agent
-
TRVI Trevi Therapeutics
$50,000,000
Follow-On
Co-Manager
-
JANX Janux Therapeutics
$402,500,000
Follow-On
Co-Manager
-
CTO CTO Realty Growth, Inc.
$25,000,000
At-the-Market – 6% Preferred Stock
Sales Agent
-
CTO CTO Realty Growth, Inc.
$250,000,000
At-the-Market
Sales Agent
-
KALV KalVista Pharmaceuticals
$55,000,000
Follow-On
Financial Advisor
-
MITT AG Mortgage Investment Trust, Inc.
$75,000,000
At-the-Market
Sole Sales Agent
-
GLMD Galmed Pharmaceuticals
$8,100,000
At-the-Market
Sole Sales Agent
-
CRNX Crinetics Pharmaceuticals
$500,000,000
Follow-On
Co-Manager
-
DMO Western Asset
$75,000,000
At-the-Market
Sole Sales Agent
-
EYPT EyePoint Pharmaceuticals
$161,000,000
Follow-On
Co-Manager
-
CALC CalciMedica, Inc
$10,200,000
Follow-On
Sole Bookrunner
-
XAIR Beyond Air
$20,600,000
Private Placement
Co-Placement Agent
-
ARR Armour Residential REIT
30,366,246 shares
Sales Agent
At-the-Market
-
MOVE Movano Health
$8,260,000
Sole Sales Agent
At-the-Market
-
CTO CTO Realty Growth Inc.
$24,500,000
Sales Agent
ATM-6% Pref. Stock
-
LEXX Lexaria Bioscience Corp
$20,000,000
Sole Sales Agent
At-the-Market
-
NRSN NeuroSense Therapeutics Ltd.
$2,500,000
Sole Sales Agent
At-the-Market
-
ELTX Elicio Therapeutics
$20,000,000
Financial Advisor
Convertible Debt
-
IVR Invesco Mortgage Capital Inc.
18,000,000 Shares
Sales Agent
At-the-Market
-
ELTX Elicio Therapeutics
$11,500,000
Sole Bookrunner
Follow-On
Contact Us
Moe Cohen
moec@jonestrading.com
212.907.5398
Bryan Turley
bturley@jonestrading.com
212.907.5398
